Literature DB >> 12939784

Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches.

Bjørn Møller1, Harald Fekjaer, Timo Hakulinen, Helgi Sigvaldason, Hans H Storm, Mats Talbäck, Tor Haldorsen.   

Abstract

Prediction of the future number of cancer cases is of great interest to society. The classical approach is to use the age-period-cohort model for making cancer incidence predictions. We made an empirical comparison of different versions of this model, using data from cancer registries in the Nordic countries for the period 1958-1997. We have applied 15 different methods to 20 sites for each sex in Denmark, Finland, Norway and Sweden. Median absolute value of the relative difference between observed and predicted numbers of cases for these 160 combinations of site, sex and country was calculated. The medians varied between 10.4 per cent and 15.3 per cent in predictions 10 years ahead, and between 15.1 per cent and 32.0 per cent for 20 year predictions. We have four main conclusions: (i) projecting current trends worked better than assuming that future rates are equal to present rates; (ii) the method based on the multiplicative APC model often overestimated the number of cancer cases due to its exponential growth over time, but using a power function to level off this growth improved the predictions; (iii) projecting only half of the trend after the first 10 years also gave better long-term predictions; (iv) methods that emphasize trends in the last decade seem to perform better than those that include earlier time trends. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12939784     DOI: 10.1002/sim.1481

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  68 in total

1.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

2.  International trends in the incidence of testicular cancer, 1973-2002.

Authors:  Victoria M Chia; Sabah M Quraishi; Susan S Devesa; Mark P Purdue; Michael B Cook; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

3.  Cancer incidence in Spain, 2015.

Authors:  J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

4.  Projecting ESRD Incidence and Prevalence in the United States through 2030.

Authors:  Keith P McCullough; Hal Morgenstern; Rajiv Saran; William H Herman; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2018-12-17       Impact factor: 10.121

5.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

6.  Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality.

Authors:  Huann-Sheng Chen; Kenneth Portier; Kaushik Ghosh; Deepa Naishadham; Hyune-Ju Kim; Li Zhu; Linda W Pickle; Martin Krapcho; Steve Scoppa; Ahmedin Jemal; Eric J Feuer
Journal:  Cancer       Date:  2012-01-06       Impact factor: 6.860

7.  Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Authors:  Jeanne S Mandelblatt; Aimee M Near; Diana L Miglioretti; Diego Munoz; Brian L Sprague; Amy Trentham-Dietz; Ronald Gangnon; Allison W Kurian; Harald Weedon-Fekjaer; Kathleen A Cronin; Sylvia K Plevritis
Journal:  Med Decis Making       Date:  2018-04       Impact factor: 2.583

8.  Projections of primary liver cancer to 2030 in 30 countries worldwide.

Authors:  Patricia C Valery; Mathieu Laversanne; Paul J Clark; Jessica L Petrick; Katherine A McGlynn; Freddie Bray
Journal:  Hepatology       Date:  2017-12-23       Impact factor: 17.425

Review 9.  Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070.

Authors:  Isabelle Soerjomataram; Freddie Bray
Journal:  Nat Rev Clin Oncol       Date:  2021-06-02       Impact factor: 66.675

10.  What is the future burden of HPV-related cancers in Spain?

Authors:  D L B de Souza; M P Curado; M M Bernal; J Jerez Roig
Journal:  Clin Transl Oncol       Date:  2013-06-20       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.